Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Zeier

Showing results (321-330 of 331) with videos related to

Pageof 34
Sort By:
JCI Insight|April 10, 2023
suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injuryChristian Nusshag, Changli Wei, Eunsil Hahm, et al.
Nature Medicine|August 2, 2011
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosisChangli Wei, Shafic El Hindi, Jing Li, et al.
Aging Cell|January 29, 2008
Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegansMichael Morcos, Xueliang Du, Friederike Pfisterer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 25, 2011
The German Chronic Kidney Disease (GCKD) study: design and methodsKai-Uwe Eckardt, Barbara Bärthlein, Seema Baid-Agrawal, et al.
Journal of the American Society of Nephrology : JASN|September 22, 2022
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant RecipientsChristian Morath, Matthias Schaier, Eman Ibrahim, et al.
Kidney International|June 21, 2023
A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior ProgramJohan de Fijter, Geertje Dreyer, Marko Mallat, et al.
The Journal of Clinical Investigation|January 29, 2020
Phase I trial of donor-derived modified immune cell infusion in kidney transplantationChristian Morath, Anita Schmitt, Christian Kleist, et al.
Nature Medicine|June 27, 2017
A tripartite complex of suPAR, APOL1 risk variants and α<sub>v</sub>β<sub>3</sub> integrin on podocytes mediates chronic kidney diseaseSalim S Hayek, Kwi Hye Koh, Morgan E Grams, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 28, 2020
Should kidney allografts from old donors be allocated only to old recipients?Caner Süsal, Gizem Kumru, Bernd Döhler, et al.
BMJ Open|November 11, 2022
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trialChristian Morath, Anita Schmitt, Michael Schmitt, et al.
Pageof 34

Showing results (321-330 of 331) with videos related to

Sort By:
Pageof 34
JCI Insight|April 10, 2023
suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injuryChristian Nusshag, Changli Wei, Eunsil Hahm, et al.
Nature Medicine|August 2, 2011
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosisChangli Wei, Shafic El Hindi, Jing Li, et al.
Aging Cell|January 29, 2008
Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegansMichael Morcos, Xueliang Du, Friederike Pfisterer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 25, 2011
The German Chronic Kidney Disease (GCKD) study: design and methodsKai-Uwe Eckardt, Barbara Bärthlein, Seema Baid-Agrawal, et al.
Journal of the American Society of Nephrology : JASN|September 22, 2022
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant RecipientsChristian Morath, Matthias Schaier, Eman Ibrahim, et al.
Kidney International|June 21, 2023
A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior ProgramJohan de Fijter, Geertje Dreyer, Marko Mallat, et al.
The Journal of Clinical Investigation|January 29, 2020
Phase I trial of donor-derived modified immune cell infusion in kidney transplantationChristian Morath, Anita Schmitt, Christian Kleist, et al.
Nature Medicine|June 27, 2017
A tripartite complex of suPAR, APOL1 risk variants and α<sub>v</sub>β<sub>3</sub> integrin on podocytes mediates chronic kidney diseaseSalim S Hayek, Kwi Hye Koh, Morgan E Grams, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 28, 2020
Should kidney allografts from old donors be allocated only to old recipients?Caner Süsal, Gizem Kumru, Bernd Döhler, et al.
BMJ Open|November 11, 2022
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trialChristian Morath, Anita Schmitt, Michael Schmitt, et al.
Pageof 34